Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines
- Author
- WINBLAD, B1 ; HILL, S2 ; BEERMANN, B3 ; POST, S. G4 ; WIMO, A5
[1] Department of Geriatric Medicine, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
[2] Department of Clinical Pharmacology, Faculty of Medicine and Health Sciences, University of Newcastle, Callaghan, Newcastle, New South Wales, Australia
[3] Medical Products Agency, Uppsala, Sweden
[4] Center for Biomedical Ethics, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
[5] Department of Family Medicine, Umea University, Umea, Sweden - Issue title
- Report of the international working group on harmonization of dementia drug guidelines
- Author (monograph)
- WHITEHOUSE, Peter J (Author of introductory parts)1
World Federation of Neurology, International (Funder/Sponsor)
World Health Organization, Geneva, Switzerland (Funder/Sponsor)
International Psychogeriatrics Association, International (Funder/Sponsor)
International Federation of Pharmaceutical Manufacturers Association, International (Funder/Sponsor)
Alzheimer's Disease International, International (Funder/Sponsor)
International Longevity Center, International (Funder/Sponsor)
[1] Alzheimer Center, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, United States - Source
Alzheimer disease and associated disorders. 1997, Vol 11, pp 39-45 ; SUP3 ; ref : 35 ref
- CODEN
- ADADE2
- ISSN
- 0893-0341
- Scientific domain
- Neurology; Psychophysiology; Psychology, psychopathology, psychiatry
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aspect économique Chimiothérapie Coût global Démence Economie santé Homme Méthodologie Problème Traitement Système nerveux pathologie Trouble neurologique
- Keyword (en)
- Economic aspect Chemotherapy Life cycle cost Dementia Health economy Human Methodology Problem Treatment Nervous system diseases Neurological disorder
- Keyword (es)
- Aspecto económico Quimioterapia Costo global Demencia Economía salud Hombre Metodología Problema Tratamiento Sistema nervioso patología Trastorno neurológico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B11 Miscellaneous
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2853025
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Alzheimer disease and associated disorders\";s:9:\"\u0000*\u0000stitle\";s:28:\"Alzheimer dis. assoc. disord\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"45\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-0341\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINBLAD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"HILL, S\";i:1;s:11:\"BEERMANN, B\";i:2;s:10:\"POST, S. G\";i:3;s:7:\"WIMO, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ADADE2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:86:\"Report of the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000title\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Alzheimer disease and associated disorders\";s:9:\"\u0000*\u0000stitle\";s:28:\"Alzheimer dis. assoc. disord\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"45\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-0341\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINBLAD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"HILL, S\";i:1;s:11:\"BEERMANN, B\";i:2;s:10:\"POST, S. G\";i:3;s:7:\"WIMO, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ADADE2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:86:\"Report of the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000title\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Alzheimer disease and associated disorders\";s:9:\"\u0000*\u0000stitle\";s:28:\"Alzheimer dis. assoc. disord\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"45\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-0341\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINBLAD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"HILL, S\";i:1;s:11:\"BEERMANN, B\";i:2;s:10:\"POST, S. G\";i:3;s:7:\"WIMO, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ADADE2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:86:\"Report of the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000title\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Alzheimer disease and associated disorders\";s:9:\"\u0000*\u0000stitle\";s:28:\"Alzheimer dis. assoc. disord\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"39\";s:8:\"\u0000*\u0000epage\";s:2:\"45\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-0341\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WINBLAD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"HILL, S\";i:1;s:11:\"BEERMANN, B\";i:2;s:10:\"POST, S. G\";i:3;s:7:\"WIMO, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ADADE2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:86:\"Report of the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000title\";s:158:\"Issues in the economic evaluation of treatment for dementia : Position paper from the international working group on harmonization of dementia drug guidelines\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
